FOR U.S. RESIDENTS ONLY
Sculptra® (injectable poly-L-lactic acid)

Healthcare Provider Quick Search
Enter your zip code to search for a healthcare provider near you.
 
Search by street address
 
Site (keyword) Providers (zip code)
References

Frequently Asked Questions

Sculptra® is intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.1 Sculptra® has been clinically proven to be an effective, well-tolerated, and long-lasting treatment for the signs of facial lipoatrophy.1

The following section is designed to help you learn more about Sculptra® and answer any questions that your patients might have.

What is Sculptra®?
How does Sculptra® work?
Are skin tests required before treatment with Sculptra®?
Are the results from Sculptra® immediate?
How many treatments are required?
How long do treatment effects last?
How quickly can my patients return to their daily activities?
When will my patients be able to apply make-up after treatment?
What are the possible side effects of treatment with Sculptra®?
Who should not use Sculptra®?

What is Sculptra®?
Sculptra® is a synthetic injectable material known as "poly-L-lactic acid." Poly-L-lactic acid is a biocompatible, biodegradable material that has been widely used for many years in dissolvable stitches, soft tissue implants, and other types of implants.2

How does Sculptra® work?
Sculptra® is injected below the surface of the skin in the area of fat loss. Sculptra® provides a gradual increase in skin thickness. Visible results appear within the first few treatment sessions.2

Sculptra® will not correct the underlying cause of the facial fat loss, but will help improve the appearance by increasing skin thickness in the treated area.2

Are skin tests required before treatment with Sculptra®?
No, skin testing is not required prior to use.2

Are the results from Sculptra® immediate?
No. After the first treatment, it may appear that Sculptra® worked immediately. Typically, patients will experience some degree of edema associated with the injection procedure, which will give the appearance of a full correction by the end of the injection session (within about 30 minutes). The patient should be informed that the injection-related edema typically resolves in several hours to a few days, resulting in the "reappearance" of the original contour deficiency. Sculptra® takes time to gradually correct the depression in the skin.1,2

How many treatments are required?
Each patient should be evaluated individually. More than one treatment session may be required. Patients with severe facial fat loss may require 3 to 6 treatment sessions.2

How long do treatment effects last?
Treatment effects will differ for each person. In a clinical study, the treatment results lasted for up to 2 years after the first treatment session, in most patients. Touch-up treatments may be needed to maintain the desired effect.1,2

How quickly can my patients return to their daily activities?
Most patients feel comfortable going back to their normal activities following treatment.1

When will my patients be able to apply make-up after treatment?
Make-up may be applied a few hours after treatment if no complications are present (for example, open wounds or bleeding).1

What are the possible side effects of treatment with Sculptra®?
The most commonly observed product-related adverse event was the delayed occurrence of subcutaneous papules (5 mm or less), which were typically palpable, asymptomatic, and non-visible, and confined to the injection site area. Other reported side effects of Sculptra® include immediate and transient injection-related events such as bleeding from the injection site, discomfort, erythema or inflammation, ecchymosis, and edema.1

Advise patients to report any side effects to their healthcare provider.

Who should not use Sculptra®?1
Sculptra® is contraindicated in those individuals who have shown a hypersensitivity to any of its components.


Sculptra® is injected into the skin for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

IMPORTANT SAFETY INFORMATION
Sculptra® is contraindicated in those individuals who have shown a hypersensitivity to any of its components. Sculptra® should not be injected in areas with active skin infection or inflammation. Avoid injection into the blood vessels.

The most commonly observed adverse event was the delayed occurrence of subcutaneous papules, which were confined to the injection site and were typically palpable, asymptomatic, and non-visible. Visible nodules, with or without inflammation or dyspigmentation, have also been reported. Other adverse events include immediate and transient injection-related events such as bleeding from the injection site, discomfort, erythema or inflammation, ecchymosis, and edema.
For more information, please see Full Product Information for Sculptra®